Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
| DRUGNAME | PT | EventCount |
|---|---|---|
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Rash generalised | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Rash pruritic | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Rectal abscess | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Septic shock | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Skin infection | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Sleep disorder | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Staphylococcal infection | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Stenosis | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Urinary retention | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Vertigo | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Viral infection | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Wound | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Wound infection pseudomonas | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Wound infection staphylococcal | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMRIC) | Febrile neutropenia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMRIC) | Lung infection | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMRIC) | Respirovirus test positive | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMRIC) | White blood cell count decreased | 1 |
| RITUXIMAB (MOABC2B8 ANTI CD20, CHIMERIC) | Bacterial test positive | 1 |
| RITUXIMAB (MOABC2B8 ANTI CD20, CHIMERIC) | Body temperature decreased | 1 |
Total Records: 1,104 Number of Pages: 56